Clinical Trials on Lymph Node Excision in Singapore
Total 326 results
-
National University Hospital, SingaporeUnknownAcute Lymphoblastic Leukemia (ALL)Singapore, Malaysia
-
Sue YomBristol-Myers Squibb; National University Cancer Institute, SingaporeActive, not recruitingNasopharyngeal CarcinomaUnited States, Singapore
-
S*BIOCompletedMyelodysplastic Syndrome | Solid Tumors | Hematologic MalignanciesUnited States, Singapore
-
Sun Yat-sen UniversityWuzhou Red Cross Hospital; Affiliated Cancer Hospital & Institute of Guangzhou... and other collaboratorsRecruitingNasopharyngeal Carcinoma | Chemotherapy | RadiotherapyChina, Singapore
-
National Cancer Institute (NCI)Active, not recruitingRecurrent Nasopharyngeal Keratinizing Squamous Cell Carcinoma | Recurrent Nasopharyngeal Undifferentiated Carcinoma | Stage IV Nasopharyngeal Keratinizing Squamous Cell Carcinoma AJCC v7 | Adult Nasal Type Extranodal NK/T-Cell Lymphoma | Stage IV Nasopharyngeal Undifferentiated Carcinoma...United States, Singapore, Japan, Hong Kong
-
Queensland Centre for Gynaecological CancerThe University of QueenslandRecruitingSurgery | Sentinel Lymph Node | Endometrial Cancer Stage IAustralia, United States, Brazil, Singapore, India
-
FibroGenAstellas Pharma IncCompletedAnemia | DialysisHong Kong, United States, Singapore, Russian Federation
-
St. Jude Children's Research HospitalActive, not recruitingMature B-Cell LymphomaUnited States, Singapore, Egypt
-
Millennium Pharmaceuticals, Inc.CompletedMultiple MyelomaHong Kong, Korea, Republic of, Singapore
-
Gleneagles HospitalSamsung Medical Center; Asan Medical Center; Chonnam National University Hospital and other collaboratorsCompletedMultiple MyelomaKorea, Republic of, Singapore, India
-
National University Hospital, SingaporeCelgene; International Myeloma Foundation; The Australasian Leukaemia & Lymphoma...UnknownRelapsed and/or Refractory Multiple MyelomaSingapore, Hong Kong, Korea, Republic of, Taiwan
-
BayerCompletedAcute Bacterial SinusitisChina, France, Germany, Indonesia, Malaysia, Saudi Arabia, Singapore, Philippines, Austria, Jordan, Lebanon, Romania, Bahrain, Egypt, United Arab Emirates, Kuwait, Netherlands, Pakistan, Yemen
-
National Cancer Centre, SingaporeGuardant Health AMEA, Inc.RecruitingNon-small Cell Lung Cancer | ALK-Positive Lung CancerKorea, Republic of, Hong Kong, Malaysia, Singapore
-
National University Hospital, SingaporeJanssen, LP; International Myeloma FoundationUnknownRelapse and / or Refractory MyelomaSingapore, Hong Kong, Taiwan, Korea, Republic of
-
Novartis PharmaceuticalsCompletedMyelofibrosisUnited Kingdom, Germany, Canada, Singapore, Netherlands, Italy, Australia, France
-
Karyopharm Therapeutics IncTerminatedCutaneous T-cell Lymphoma (CTCL) | Peripheral T-cell Lymphoma (PTCL)Australia, Singapore
-
National University Hospital, SingaporeCelgene; International Myeloma FoundationUnknownRelapse Multiple MyelomaSingapore, Hong Kong, Japan, Korea, Republic of, Taiwan
-
Novartis PharmaceuticalsCompletedParoxysmal Nocturnal HemoglobinuriaTaiwan, Singapore, Korea, Republic of, Malaysia
-
National Cancer Institute (NCI)CompletedRefractory Multiple MyelomaUnited States, Singapore
-
Janssen Research & Development, LLCCompletedLymphomaTaiwan, China, Singapore, Korea, Republic of, Hong Kong
-
Shanghai Proton and Heavy Ion CenterFudan University; West China Hospital; Tongji Hospital; Peking University Cancer... and other collaboratorsUnknownNasopharyngeal CarcinomaChina, Taiwan, Singapore
-
Novartis PharmaceuticalsCompletedAdvanced Solid and Hematological TP53wt TumorsFrance, Netherlands, Spain, Germany, Singapore, Japan, Taiwan, United States
-
Novartis PharmaceuticalsActive, not recruitingAdvanced Malignancies That Harbor IDHR132 MutationsBelgium, Germany, Spain, Canada, Australia, United States, Netherlands, Singapore
-
Samsung Medical CenterCompletedPatients With Diffuse Large B-cell Lymphoma or Follicular Lymphoma | Patients Treated With Rituximab-CHOP or Rituximab-CVPKorea, Republic of, Malaysia, Singapore, China
-
Cullinan Oncology, LLCNational Cancer Institute (NCI)TerminatedNasopharyngeal Carcinoma | Nasopharyngeal CancerFrance, Singapore, United States, China, Hong Kong
-
Novartis PharmaceuticalsCompletedSolid Tumors | LymphomasSpain, Canada, Singapore, Israel, Japan, United States
-
Abbott Medical DevicesActive, not recruitingHeart Failure | Heart Block | Bradycardia | Syncope | Cardiomyopathies | Sinus Node DysfunctionUnited States, Singapore, France, India, Italy
-
Novartis PharmaceuticalsCompletedRelapsed and Refractory Multiple MyelomaItaly, Germany, Singapore, Australia, United States
-
Singapore General HospitalCompletedAngioimmunoblastic T-cell Lymphoma | Hepatosplenic T-cell Lymphoma | Peripheral T-cell Lymphoma (Not Otherwise Specified) | Extranodal NK/T-cell Lymphoma Nasal Type | Enteropathy- Type T-cell Lymphoma | Anaplastic Large Cell Lymphoma (ALCL) (ALK-1 Negative) | Relapsed ALCL (ALK-1 Positive) Post...Singapore, Malaysia, Korea, Republic of
-
Novartis PharmaceuticalsCompletedMultiple MyelomaUnited States, Germany, Spain, Singapore
-
Novartis PharmaceuticalsCompletedRelapsed or Refractory Multiple MyelomaGermany, Spain, Singapore, United States, Australia
-
EDDC (Experimental Drug Development Centre), A*STAR...Chiltern International Inc.WithdrawnPh+ Acute Lymphoblastic Leukemia (Ph+ALL) | Ph- Acute Lymphoblastic Leukemia (Ph-ALL) | Chronic Myeloid Leukemia Accelerated Phase (CML-AP, Ph+) | Chronic Myeloid Leukemia Blast Crisis (CML-BC, Ph+)United States, Singapore
-
Novartis PharmaceuticalsActive, not recruitingMultiple MyelomaUnited States, Singapore, Israel, Australia
-
Novo Nordisk A/SCompletedAcquired Bleeding Disorder | Intracerebral HaemorrhageFinland, Singapore, Australia, Spain, Denmark, Germany, Italy, Taiwan, United Kingdom
-
Novartis PharmaceuticalsIncyte CorporationTerminatedMyelofibrosisSpain, United Kingdom, Australia, Israel, Germany, Italy, Singapore, Austria, France
-
St. Joseph's Healthcare HamiltonMcMaster UniversityCompletedThrombosis | Bleeding | CoagulationCanada, Singapore, United States, Italy
-
University of CanterburyTan Tock Seng Hospital; University of Toronto; Fremantle Hospital and Health... and other collaboratorsCompletedStroke | Dysphagia | Cerebrovascular AccidentSingapore, Canada, Australia, New Zealand
-
Novo Nordisk A/SCompletedTrauma | Acquired Bleeding DisorderGermany, Austria, Israel, France, Canada, Singapore, South Africa, Australia, United Kingdom
-
Novartis PharmaceuticalsRecruitingMyeloid DiseasesUnited States, Italy, Spain, Singapore, France, Hong Kong, Germany
-
Novartis PharmaceuticalsActive, not recruitingChronic Lymphocytic Leukemia | Non-Hodgkins LymphomaFinland, Spain, Korea, Republic of, Israel, Japan, Germany, Singapore
-
Novartis PharmaceuticalsActive, not recruitingAcute Myeloid Leukemia (AML) | High-risk Myelodysplastic Syndrome (MDS)Spain, Singapore, Australia, Germany, Italy, Finland, United States
-
National Cancer Institute (NCI)CompletedRecurrent Squamous Cell Carcinoma of the Nasopharynx | Stage IV Squamous Cell Carcinoma of the NasopharynxUnited States, Singapore, China
-
National Hospital Organization Nagoya Medical CenterRecruitingAcute Lymphoblastic Leukemia | Down Syndrome | Childhood CancerTaiwan, Thailand, Hong Kong, Singapore, Malaysia, Japan
-
Novartis PharmaceuticalsCompletedNon-small Cell Lung Cancer | Anaplastic Lymphoma Kinase (ALK)Australia, Spain, Singapore, Italy, United States
-
Novartis PharmaceuticalsTerminatedMyelodysplastic SyndromesUnited States, Spain, Italy, Singapore, Korea, Republic of, Israel, Australia
-
Shanghai Junshi Bioscience Co., Ltd.Active, not recruitingRecurrent or Metastatic NPCChina, Taiwan, Singapore
-
Dren BioNovotech (Australia) Pty LimitedRecruitingB-cell Non Hodgkin LymphomaAustralia, Hong Kong, Korea, Republic of, Singapore, Taiwan
-
Novo Nordisk A/SCompletedTrauma | Acquired Bleeding DisorderIndia, Spain, Canada, Finland, Germany, Israel, Italy, Netherlands, Singapore, Switzerland, Taiwan
-
Duke UniversityActive, not recruitingDiffuse Large B Cell LymphomaUnited States, Japan, Italy, Korea, Republic of, Czechia, Singapore
-
National Cancer Institute (NCI)Active, not recruitingRecurrent Grade 1 Follicular Lymphoma | Recurrent Grade 2 Follicular Lymphoma | Recurrent Grade 3 Follicular Lymphoma | Refractory Follicular Lymphoma | Grade 3a Follicular LymphomaUnited States, Canada, Singapore